From 2024 to 2028, hospital discharges for adnexa and eye diseases in France show a decreasing trend. The forecast predicts a decline from 68.19 thousand in 2024 to 31.25 thousand in 2028. This represents an approximate annual decrease of about 16.5%, based on the available data, indicating a significant reduction in these cases.
Future trends to watch include advancements in outpatient care and non-invasive treatments, which may continue to reduce hospital discharges. Additionally, improvements in early detection and preventive measures, like screening programs and new ophthalmic technologies, could further impact these figures in France.
